Identification of c[D-Trp-Phe-β-Ala-β-Ala], the First κ-Opioid Receptor-Specific Negative Allosteric Modulator.

Area of Science:

• Medicinal Chemistry
• Neuropharmacology
• Natural Products

Background:

• Cyclotetrapeptides like CJ-15,208, derived from fungi, exhibit unique structures and biological activities.
• Tryptophan-containing noncationic opioid peptides can activate multiple opioid receptors.
• The kappa opioid receptor (KOR) plays a crucial role in central nervous system functions such as pain, mood, and reward.

Purpose of the Study:

• To investigate the structure-activity relationships of fungal cyclotetrapeptides.
• To identify novel modulators of the kappa opioid receptor (KOR).
• To develop a KOR-specific negative allosteric modulator (NAM) for potential therapeutic applications.

Main Methods:

• Chemical synthesis and modification of cyclotetrapeptide derivatives.
• In vitro and in vivo assays to evaluate opioid receptor activity.
• Pharmacological characterization of KOR agonism and allosteric modulation.

Main Results:

• A minimal modification of a known KOR agonist resulted in a highly selective KOR-specific negative allosteric modulator (NAM).
• Compound 11, c[D-Trp-Phe-β-Ala-β-Ala], was identified as the first KOR-specific NAM.
• The developed NAM demonstrates potential for targeted modulation of KOR activity.

Conclusions:

• The discovery of a KOR-specific NAM represents a significant advancement in opioid receptor pharmacology.
• This novel compound holds promise for the development of new treatments for addiction and neuropsychiatric disorders.
• Targeting KOR with specific NAMs offers a refined approach to modulating complex neurological functions.